InVitria’s Animal-free Cell Culture Supplements Now Available Through Several Worldwide and Regional Distributors
Fort Collins, CO, USA, September 29, 2011 / B3C newswire / – InVitria announced expansion of its distribution network to include multiple regional and worldwide distributors. InVitria’s distribution network will provide regional distribution options for customers in North America, Europe, Asia, and Australia. Regional distributors join InVitria’s worldwide distributors: Sigma-Aldrich and Thermo Fisher Scientific.
InVitria’s product line of animal component-free cell culture media products are also available in bulk and online at www.InVitria.com as well as through the online catalogue of its distributor network. Eight regional distributors have now been added to this list to provide additional convenience and local service for InVitria’s global customer base. InVitria products have been shown to improve productivity, increase safety, and reduce the costs of cell culture production.
“InVitria has selected eight regional distributors to represent North America, Europe, Asia, and Australia. These distributors will join our current worldwide distributors, Sigma-Aldrich and Thermo Fisher Scientific, to provide customers with multiple purchasing options to best fit their needs,” said Shawn Smith, InVitria’s Vice President of Sales.
“InVitria’s products address the main issues facing cell culture systems today: improving productivity, enhancing consistency, and removing animal components from media,” said Scott Deeter, InVitria’s President. He added that, “these problems affect biomanufacturing worldwide and expanding our distribution network provides more options for our international customers.”
To see a full list of InVitria distributors by product please visit www.InVitria.com
InVitria develops, manufactures, and markets a portfolio of products used in cell culture, diagnostics, medical devices and bioproduction. InVitria’s products address customer needs for defined, animal component free reagents in stem cell technology, regenerative medicine, biomanufacturing, diagnostics, biopharmaceutical formulation, cell-based vaccines, and general life science research.